SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-19-044678
Filing Date
2019-08-08
Accepted
2019-08-08 06:07:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a19-16799_1424b5.htm 424B5 482221
2 GRAPHIC g167991aai001.jpg GRAPHIC 4247
3 GRAPHIC g167991hoi001.jpg GRAPHIC 4247
  Complete submission text file 0001104659-19-044678.txt   495184
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-230341 | Film No.: 191007327
SIC: 2834 Pharmaceutical Preparations